Company news
Cumberland Pharmaceuticals Inc. news in 2022
Cumberland Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.
Cumberland Pharmaceuticals Reports 41% Revenue Growth
November 7, 2022
Cumberland Pharmaceuticals moves into new headquarters at Broadwest
October 31, 2022
Cumberland Pharmaceuticals Reports 14% Revenue Growth
August 8, 2022
Cumberland Pharmaceuticals reports 2.4M patient doses delivered, no product recalls, no FDA issues in 2021
August 7, 2022
Cumberland Pharmaceuticals to announce second quarter 2022 financial results
August 1, 2022
Cumberland Pharmaceuticals appoints martin brown jr. to its board of directors
July 18, 2022
Cumberland Pharmaceuticals Reports 6% Revenue Growth
May 9, 2022
Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso®
May 8, 2022
Cumberland Pharmaceuticals to announce first quarter 2022 financial results
May 2, 2022
Cumberland Pharmaceuticals reports 2021 financial results & company update
March 7, 2022
Cumberland Pharmaceuticals to announce annual 2021 financial results
February 28, 2022
Cumberland Pharmaceuticals acquires SANCUSO® from Kyowa Kirin north america
January 3, 2022
Calls in 2022
- Cumberland Pharmaceuticals (NASDAQ:CPIX) Q3 2022 Earnings Call
Nov 8, 2022
Transcript - Cumberland Pharmaceuticals (NASDAQ:CPIX) Q2 2022 Earnings Call
Aug 9, 2022
Transcript - Cumberland Pharmaceuticals (NASDAQ:CPIX) Q1 2022 Earnings Call
May 10, 2022
Transcript - Cumberland Pharmaceuticals (NASDAQ:CPIX) Q4 2021 Earnings Call
Mar 8, 2022
Transcript